OGS/Glaxo biomarker deal

Big Deal - good deal? Or is there a better deal?

Deal or No Deal? - Asessing the Daily Deal Shopper

We build upon previous work done in online shopping segmentation but follow a customer-revealed approach by using an explorative cluster analysis on a sample of 11,848 daily deal shoppers located in Switzerland. We identify six segments into which the daily deal shoppers can be categorized: recreational shoppers, mobile shoppers, traditionalists, bargain hunters, socializers, and convenience se...

Von Willebrand factor for predicting bleeding and mortality real deal or another failed biomarker?

One of the largest controversies and unsolved mysteries of modern medicine is the uncertain relationship among the utility of laboratory biomarkers as reliable predictors of adverse clinical events. Unquestionably, adequate assessment of bleeding and death risks is the most desirable but hard to reach goal, especially in a cardiology clinic. A timely, elegant, well-designed study in 800 patient...

What Makes a Hot Deal? Drivers of Deal Popularity in Online Deal Communities

Online deal communities where members can submit deals offered by firms and where they share information on discounted products are currently enjoying great popularity. However, studies on drivers of deal popularity in these communities are still scarce. Although deal popularity may be attributed to a large extent to the discount price, an extensive investigation of why some deals are voted mor...

Risky Choice and Type Uncertainty in ‘Deal or No Deal’

This paper uses data from the popular television game-show, "Deal or No Deal?", to analyse the way individuals make choices under risk. In a unique approach to the problem, I present a formal game-theoretical model of the show in which both the contestant and the banker are modelled as strategic players. I use standard techniques to form hypotheses of how rational expected utility-maximisers wo...